
Cancer Tumor Profiling Market In-depth Research covering sales outlook, demand forecast & up-to-date key trends
Cancer Tumor Profiling Market by End User (Office Building Construction, Retail Construction, Hospitality Construction, Institutional Construction, Other End Users), by North America (United States, Canada, Mexico), by South America (Brazil, Argentina, Rest of South America), by Europe (United Kingdom, Germany, France, Italy, Spain, Russia, Benelux, Nordics, Rest of Europe), by Middle East & Africa (Turkey, Israel, GCC, North Africa, South Africa, Rest of Middle East & Africa), by Asia Pacific (China, India, Japan, South Korea, ASEAN, Oceania, Rest of Asia Pacific) Forecast - is a comprehensive report that provides insights into the market dynamics, including the key drivers, challenges, and opportunities shaping the industry landscape. It also delves into the competitive landscape, highlighting the major players and their strategies.
Exclusive deal : 20% Instant discount on Direct purchases! Don't wait—claim your discount today!
The global Cancer Tumor Profiling market is expected to grow at a CAGR of 10.8% during the forecast period.
The global Cancer Tumor Profiling market is estimated to be about 37000.7 million US dollars in 2020.
The global Cancer Tumor Profiling market is estimated to reach 55745.8 million USD by 2026.
The global Cancer Tumor Profiling market is segmented by company, region (country), type and application. Participants, stakeholders, and other readers in the global Cancer Tumor Profiling market will be able to gain an advantage as they use reports as a powerful resource.
Cancer Tumor Profiling markets by category
Next-generation Sequencing (NGS)
Polymerase Chain Reaction (PCR)
Immunohistochemistry (IHC)
In Situ Hybridization (ISH)
Microarray
Others
Cancer Tumor Profiling Market by Application (Percentage of Demand)
Personalized Medicine
Diagnostics
Biomarker Discovery
Prognostics
Research Applications
Who are the leading companies in Cancer Tumor Profiling
Qiagen N.V.
Roche Molecular Systems Inc.
Abott Molecular
Illumina Inc.
NeoGenomics Laboratories
HTG Molecular Diagnostic
Genomic Health Inc.
Hologic Gen-Probe
BD Biosciences
Siemens Healthineers
Claris Life Sciences
Personal Genome Diagnostics, Inc.
Perthera, Inc.
Foundation Medicine, Inc
V., Strand
ApoCell
Contextual Genomics
Agendia
GenScript
Cancer Tumor Profiling markets by region:
In North America
In Latin America
Europe
The Asia-pacific
Middle East and Africa (MEA)
What are the main countries covered
The United States
Canada
Germany
France
UK
Italy
Russia
China
Japan
Korea
Southeast Asia
India
Australia
Brazil
Mexico
Argentina
Chile
Colombia
Egypt
Saudi Arabia
United Arab Emirates
Nigeria
South Africa
Which is the most profitable market
Among regions, North America/Europe/Asia Pacific accounted for the largest share of global personalized beauty equipment as rising consumer incomes led to increased spending at Cancer Tumor Profiling.
What methodology did you follow in your research
This study was conducted by our expert analysts through a combination of primary and secondary studies. The methodology we follow includes a demand-side assessment of the market and triangulation of this through supply-side analysis. The methodology is based on the use of standard market structures, methods, and definitions.
Who were the primary study respondents
We talk to stakeholders across the spectrum. Including C-level executives, distributors, product manufacturers, industry experts, etc.
What are the sources of secondary research
We conduct extensive secondary studies using proprietary databases, paid databases, and information available in the public domain. We refer to industry associations, company press releases, annual reports, investor presentations and research papers.
1. Introduction
1.1 Definition of the Market
1.2 Research Purpose
1.3 Scope of the Study
1.4 Stakeholders
1.5 Geography Coverage
1.6 Currency Under Consideration
1.7 Market Size Units
1.8 Review Cycle
2 Global Market Overview
2.1 Global Cancer Tumor Profiling Revenue and Growth Forecast 2014-2026
2.2 Global Cancer Tumor Profiling Market Size and Growth Forecast 2014-2026
2.3 Global Cancer Tumor Profiling Revenue by Region 2014-2026
2.4 Cancer Tumor Profiling Market Share by Major Regions 2014-2021
2.5 Cancer Tumor Profiling Gross Margin in Different Region 2014-2021
2.6 Global Cancer Tumor Profiling Market History Price and Forecast 2014-2026
2.7 Global Cancer Tumor Profiling Sales Market Share by Top Companies 2014-2021
3 Global Cancer Tumor Profiling Market by Type
3.1 Global Cancer Tumor Profiling Revenue and Growth Rate Segment by Types from 2014-2021
3.2 Global Cancer Tumor Profiling Market Size and Growth Rate Segment by Product Types from 2014-2021
3.3 Global Cancer Tumor Profiling Price Segment by Types from 2014-2021
3.4 Brief Introduction of Different Types
3.4.1 Next-generation Sequencing (NGS)
3.4.2 Polymerase Chain Reaction (PCR)
3.4.3 Immunohistochemistry (IHC)
3.4.4 In Situ Hybridization (ISH)
3.4.5 Microarray
3.4.6 Others
4 Global Cancer Tumor Profiling Market by Application
4.1 Global Cancer Tumor Profiling Revenue and Growth Rate Segment by Applications from 2014-2021
4.2 Global Cancer Tumor Profiling Market Size and Growth Rate Segment by Product Applications from 2014-2021
4.3 Brief Introduction of Different Applications
4.3.1 Personalized Medicine
4.3.2 Diagnostics
4.3.3 Biomarker Discovery
4.3.4 Prognostics
4.3.5 Research Applications
5 North America Cancer Tumor Profiling Market (Value, Market Size, Import, Export) and Segmentation (by Type, Application, Countries and Participants)
5.1 North America Cancer Tumor Profiling Value ($) from 2014-2021
5.2 North America Cancer Tumor Profiling Market Size from 2014-2021
5.3 North America Cancer Tumor Profiling Price Change from 2014-2021
5.4 North America Cancer Tumor Profiling Import and Export from 2014-2021
5.5 North America Cancer Tumor Profiling Market Value ($) and Growth (%) by Type from 2014-2021
5.6 North America Cancer Tumor Profiling Market Value ($) and Growth (%) by Application from 2014-2021
5.7 North America Cancer Tumor Profiling Market Value ($) and Growth (%) by Countries from 2014-2021
5.7.1 The United States
5.7.2 Canada
5.8 Top North America Cancer Tumor Profiling Participants Value ($) and Market Share (%) in 2020
6 Europe Cancer Tumor Profiling Market (Value, Market Size, Import, Export) and Segmentation (by Type, Application, Countries and Participants)
6.1 Europe Cancer Tumor Profiling Value ($) from 2014-2021
6.2 Europe Cancer Tumor Profiling Market Size from 2014-2021
6.3 Europe Cancer Tumor Profiling Price Change from 2014-2021
6.4 Europe Cancer Tumor Profiling Import and Export from 2014-2021
6.5 Europe Cancer Tumor Profiling Market Value ($) and Growth (%) by Type from 2014-2021
6.6 Europe Cancer Tumor Profiling Market Value ($) and Growth (%) by Application from 2014-2021
6.7 Europe Cancer Tumor Profiling Market Value ($) and Growth (%) by Countries from 2014-2021
6.7.1 Germany
6.7.2 France
6.7.3 UK
6.7.4 Italy
6.7.5 Russia
…
6.8 Top Europe Cancer Tumor Profiling Participants Value ($) and Market Share (%) in 2020
7 Asia-Pacific Cancer Tumor Profiling Market (Value, Market Size, Import, Export) and Segmentation (by Type, Application, Countries and Participants)
7.1 Asia-Pacific Cancer Tumor Profiling Value ($) from 2014-2021
7.2 Asia-Pacific Cancer Tumor Profiling Market Size from 2014-2021
7.3 Asia-Pacific Cancer Tumor Profiling Price Change from 2014-2021
7.4 Asia-Pacific Cancer Tumor Profiling Import and Export from 2014-2021
7.5 Asia-Pacific Cancer Tumor Profiling Market Value ($) and Growth (%) by Type from 2014-2021
7.6 Asia-Pacific Cancer Tumor Profiling Market Value ($) and Growth (%) by Application from 2014-2021
7.7 Asia-Pacific Cancer Tumor Profiling Market Value ($) and Growth (%) by Countries from 2014-2021
7.7.1 China
7.7.2 Japan
7.7.3 Korea
7.7.4 Southeast Asia
7.7.5 India
7.7.6 Australia
…
7.8 Top Asia-Pacific Cancer Tumor Profiling Participants Value ($) and Market Share (%) in 2020
8 Latin America Cancer Tumor Profiling Market (Value, Market Size, Import, Export) and Segmentation (by Type, Application, Countries and Participants)
8.1 Latin America Cancer Tumor Profiling Value ($) from 2014-2021
8.2 Latin America Cancer Tumor Profiling Market Size from 2014-2021
8.3 Latin America Cancer Tumor Profiling Price Change from 2014-2021
8.4 Latin America Cancer Tumor Profiling Import and Export from 2014-2021
8.5 Latin America Cancer Tumor Profiling Market Value ($) and Growth (%) by Type from 2014-2021
8.6 Latin America Cancer Tumor Profiling Market Value ($) and Growth (%) by Application from 2014-2021
8.7 Latin America Cancer Tumor Profiling Market Value ($) and Growth (%) by Countries from 2014-2021
8.7.1 Brazil
8.7.2 Mexico
8.7.3 Argentina
8.7.4 Chile
8.7.5 Colombia
…
8.8 Top Latin America Cancer Tumor Profiling Participants Value ($) and Market Share (%) in 2020
9 Middle East & Africa Cancer Tumor Profiling Market (Value, Market Size, Import, Export) and Segmentation (by Type, Application, Countries and Participants)
9.1 Middle East & Africa Cancer Tumor Profiling Value ($) from 2014-2021
9.2 Middle East & Africa Cancer Tumor Profiling Market Size from 2014-2021
9.3 Middle East & Africa Cancer Tumor Profiling Price Change from 2014-2021
9.4 Middle East & Africa Cancer Tumor Profiling Import and Export from 2014-2021
9.5 Middle East & Africa Cancer Tumor Profiling Market Value ($) and Growth (%) by Type from 2014-2021
9.6 Middle East & Africa Cancer Tumor Profiling Market Value ($) and Growth (%) by Application from 2014-2021
9.7 Middle East & Africa Cancer Tumor Profiling Market Value ($) and Growth (%) by Countries from 2014-2021
9.7.1 Egypt
9.7.2 Saudi Arabia
9.7.3 United Arab Emirates
9.7.4 Nigeria
9.7.5 South Africa
…
9.8 Top Middle East & Africa Cancer Tumor Profiling Participants Value ($) and Market Share (%) in 2020
10. Global Level Competitive Intelligence – Company Profiles
10.1 Qiagen N.V.
10.1.1 Qiagen N.V. Company Profile (Major Business, Plants Distribution, Sales Region, Contact Information)
10.1.2 Qiagen N.V. Sales, Value, Gross and Gross Margin from 2014-2021
10.1.3 Qiagen N.V. Value and Growth Change from 2014-2021
10.1.4 Qiagen N.V. Price Change from 2014-2021
10.1.5 Qiagen N.V. Product Offered
10.2 Roche Molecular Systems Inc.
10.2.1 Roche Molecular Systems Inc. Company Profile (Major Business, Plants Distribution, Sales Region, Contact Information)
10.2.2 Roche Molecular Systems Inc. Sales, Value, Gross and Gross Margin from 2014-2021
10.2.3 Roche Molecular Systems Inc. Value and Growth Change from 2014-2021
10.2.4 Roche Molecular Systems Inc. Price Change from 2014-2021
10.2.5 Roche Molecular Systems Inc. Product Offered
10.3 Abott Molecular
10.3.1 Abott Molecular Company Profile (Major Business, Plants Distribution, Sales Region, Contact Information)
10.3.2 Abott Molecular Sales, Value, Gross and Gross Margin from 2014-2021
10.3.3 Abott Molecular Value and Growth Change from 2014-2021
10.3.4 Abott Molecular Price Change from 2014-2021
10.3.5 Abott Molecular Product Offered
10.4 Illumina Inc.
10.4.1 Illumina Inc. Company Profile (Major Business, Plants Distribution, Sales Region, Contact Information)
10.4.2 Illumina Inc. Sales, Value, Gross and Gross Margin from 2014-2021
10.4.3 Illumina Inc. Value and Growth Change from 2014-2021
10.4.4 Illumina Inc. Price Change from 2014-2021
10.4.5 Illumina Inc. Product Offered
10.5 NeoGenomics Laboratories
10.5.1 NeoGenomics Laboratories Company Profile (Major Business, Plants Distribution, Sales Region, Contact Information)
10.5.2 NeoGenomics Laboratories Sales, Value, Gross and Gross Margin from 2014-2021
10.5.3 NeoGenomics Laboratories Value and Growth Change from 2014-2021
10.5.4 NeoGenomics Laboratories Price Change from 2014-2021
10.5.5 NeoGenomics Laboratories Product Offered
10.6 HTG Molecular Diagnostic
10.6.1 HTG Molecular Diagnostic Company Profile (Major Business, Plants Distribution, Sales Region, Contact Information)
10.6.2 HTG Molecular Diagnostic Sales, Value, Gross and Gross Margin from 2014-2021
10.6.3 HTG Molecular Diagnostic Value and Growth Change from 2014-2021
10.6.4 HTG Molecular Diagnostic Price Change from 2014-2021
10.6.5 HTG Molecular Diagnostic Product Offered
10.7 Genomic Health Inc.
10.7.1 Genomic Health Inc. Company Profile (Major Business, Plants Distribution, Sales Region, Contact Information)
10.7.2 Genomic Health Inc. Sales, Value, Gross and Gross Margin from 2014-2021
10.7.3 Genomic Health Inc. Value and Growth Change from 2014-2021
10.7.4 Genomic Health Inc. Price Change from 2014-2021
10.7.5 Genomic Health Inc. Product Offered
10.8 Hologic Gen-Probe
10.8.1 Hologic Gen-Probe Company Profile (Major Business, Plants Distribution, Sales Region, Contact Information)
10.8.2 Hologic Gen-Probe Sales, Value, Gross and Gross Margin from 2014-2021
10.8.3 Hologic Gen-Probe Value and Growth Change from 2014-2021
10.8.4 Hologic Gen-Probe Price Change from 2014-2021
10.8.5 Hologic Gen-Probe Product Offered
10.9 BD Biosciences
10.9.1 BD Biosciences Company Profile (Major Business, Plants Distribution, Sales Region, Contact Information)
10.9.2 BD Biosciences Sales, Value, Gross and Gross Margin from 2014-2021
10.9.3 BD Biosciences Value and Growth Change from 2014-2021
10.9.4 BD Biosciences Price Change from 2014-2021
10.9.5 BD Biosciences Product Offered
10.10 Siemens Healthineers
10.10.1 Siemens Healthineers Company Profile (Major Business, Plants Distribution, Sales Region, Contact Information)
10.10.2 Siemens Healthineers Sales, Value, Gross and Gross Margin from 2014-2021
10.10.3 Siemens Healthineers Value and Growth Change from 2014-2021
10.10.4 Siemens Healthineers Price Change from 2014-2021
10.10.5 Siemens Healthineers Product Offered
10.11 Claris Life Sciences
10.11.1 Claris Life Sciences Company Profile (Major Business, Plants Distribution, Sales Region, Contact Information)
10.11.2 Claris Life Sciences Sales, Value, Gross and Gross Margin from 2014-2021
10.11.3 Claris Life Sciences Value and Growth Change from 2014-2021
10.11.4 Claris Life Sciences Price Change from 2014-2021
10.11.5 Claris Life Sciences Product Offered
10.12 Personal Genome Diagnostics, Inc.
10.12.1 Personal Genome Diagnostics, Inc. Company Profile (Major Business, Plants Distribution, Sales Region, Contact Information)
10.12.2 Personal Genome Diagnostics, Inc. Sales, Value, Gross and Gross Margin from 2014-2021
10.12.3 Personal Genome Diagnostics, Inc. Value and Growth Change from 2014-2021
10.12.4 Personal Genome Diagnostics, Inc. Price Change from 2014-2021
10.12.5 Personal Genome Diagnostics, Inc. Product Offered
10.13 Perthera, Inc.
10.13.1 Perthera, Inc. Company Profile (Major Business, Plants Distribution, Sales Region, Contact Information)
10.13.2 Perthera, Inc. Sales, Value, Gross and Gross Margin from 2014-2021
10.13.3 Perthera, Inc. Value and Growth Change from 2014-2021
10.13.4 Perthera, Inc. Price Change from 2014-2021
10.13.5 Perthera, Inc. Product Offered
10.14 Foundation Medicine, Inc
10.14.1 Foundation Medicine, Inc Company Profile (Major Business, Plants Distribution, Sales Region, Contact Information)
10.14.2 Foundation Medicine, Inc Sales, Value, Gross and Gross Margin from 2014-2021
10.14.3 Foundation Medicine, Inc Value and Growth Change from 2014-2021
10.14.4 Foundation Medicine, Inc Price Change from 2014-2021
10.14.5 Foundation Medicine, Inc Product Offered
10.15 V., Strand
10.15.1 V., Strand Company Profile (Major Business, Plants Distribution, Sales Region, Contact Information)
10.15.2 V., Strand Sales, Value, Gross and Gross Margin from 2014-2021
10.15.3 V., Strand Value and Growth Change from 2014-2021
10.15.4 V., Strand Price Change from 2014-2021
10.15.5 V., Strand Product Offered
10.16 ApoCell
10.16.1 ApoCell Company Profile (Major Business, Plants Distribution, Sales Region, Contact Information)
10.16.2 ApoCell Sales, Value, Gross and Gross Margin from 2014-2021
10.16.3 ApoCell Value and Growth Change from 2014-2021
10.16.4 ApoCell Price Change from 2014-2021
10.16.5 ApoCell Product Offered
10.17 Contextual Genomics
10.17.1 Contextual Genomics Company Profile (Major Business, Plants Distribution, Sales Region, Contact Information)
10.17.2 Contextual Genomics Sales, Value, Gross and Gross Margin from 2014-2021
10.17.3 Contextual Genomics Value and Growth Change from 2014-2021
10.17.4 Contextual Genomics Price Change from 2014-2021
10.17.5 Contextual Genomics Product Offered
10.18 Agendia
10.18.1 Agendia Company Profile (Major Business, Plants Distribution, Sales Region, Contact Information)
10.18.2 Agendia Sales, Value, Gross and Gross Margin from 2014-2021
10.18.3 Agendia Value and Growth Change from 2014-2021
10.18.4 Agendia Price Change from 2014-2021
10.18.5 Agendia Product Offered
10.19 GenScript
10.19.1 GenScript Company Profile (Major Business, Plants Distribution, Sales Region, Contact Information)
10.19.2 GenScript Sales, Value, Gross and Gross Margin from 2014-2021
10.19.3 GenScript Value and Growth Change from 2014-2021
10.19.4 GenScript Price Change from 2014-2021
10.19.5 GenScript Product Offered
11. Market Dynamics
11.1 Driving Factors
11.1.1 Rising Demand in Some Regions: North America/Europe/China/India/Japan …
11.1.2 Increasing Use of Cancer Tumor Profiling by Different End-User/Applications
11.2 Restraints and Challenges in the Market
11.3 Opportunities
11.4 Covid-19 Impact/Evaluation
12. Future Forecast of Global Cancer Tumor Profiling Market from 2020-2026
12.1 Future Forecast of Global Cancer Tumor Profiling Market from 2020-2026 Segment by Regions
12.2 Future Forecast of Global Cancer Tumor Profiling Market from 2020-2026 Segment by Type
12.3 Future Forecast of Global Cancer Tumor Profiling Market from 2020-2026 Segment by Application
13. Investment Analysis
13.1 Fundamental Analysis (Porter's Five Forces Analysis)
13.2 Technical Preparation Analysis
13.3 Risk Evaluating Analysis
13.4 Estimated Investment Pay-Back Period
14 Research Methodology
14.1 Research Data
14.1.1 Secondary Data
14.1.2 Primary Data
14.2 Revenue Estimation
14.2.1 Bottom-Up Approach
14.2.2 Top-Down Approach (Involves time, Space, and Persons)
14.3 Data Triangulation
14.4 Assumptions
14.5 Hypothesis of this Research, Clear, specific, and testable statement of this research
14.6 Limitations of Our Study
14.7 Scene Based Modeling
15 Disclaimer
Research Methodology:
Cancer Tumor Profiling Market Size Estimation
To estimate market size and trends, we use a combination of top-down and bottom-up methods. This allows us to evaluate the market from various perspectives—by company, region, product type, and end users.
Our estimates are based on actual sales data, excluding any discounts. Segment breakdowns and market shares are calculated using weighted averages based on usage rates and average prices. Regional insights are determined by how widely a product or service is adopted in each area.
Key companies are identified through secondary sources like industry reports and company filings. We then verify revenue estimates and other key data points through primary research, including interviews with industry experts, company executives, and decision-makers.
We take into account all relevant factors that could influence the market and validate our findings with real-world input. Our final insights combine both qualitative and quantitative data to provide a well-rounded view. Please note, these estimates do not account for unexpected changes such as inflation, economic downturns, or policy shifts.
Data Source
Secondary Sources
This study draws on a wide range of secondary sources, including press releases, annual reports, non-profit organizations, industry associations, government agencies, and customs data. We also referred to reputable databases and directories such as Bloomberg, Wind Info, Hoovers, Factiva, Trading Economics, Statista, and others. Additional references include investor presentations, company filings (e.g., SEC), economic data, and documents from regulatory and industry bodies.
These sources were used to gather technical and market-focused insights, identify key players, analyze market segmentation and classification, and track major trends and developments across industries.
Market Size |
|
|
Market Position of Top Company |
|
|
Qualitative Analysis |
|
|
Primary Sources
As part of our primary research, we interviewed a variety of stakeholders from both the supply and demand sides to gather valuable qualitative and quantitative insights.
On the supply side, we spoke with product manufacturers, competitors, industry experts, research institutions, distributors, traders, and raw material suppliers. On the demand side, we engaged with business leaders, marketing and sales heads, technology and innovation directors, supply chain executives, and end users across key organizations.
These conversations helped us better understand market segmentation, pricing, applications, leading players, supply chains, demand trends, industry outlook, and key market dynamics—including risks, opportunities, barriers, and strategic developments.
Key Data Information from Primary Sources
Primary Sources | Parameters | Key Data |
Market Segments(by Application, by Type) |
|
|
Total Market |
|
|